TK
Tarsem Kumar Ruby
About Tarsem Kumar Ruby
Data last updated:
Tarsem Kumar Ruby is a Director at Ojas Medical Services Private Limited (since 2015), Director at Raymed Ophthalmic Private Limited (since 2019) and Director at Raymed Pharmaceuticals Limited (since 1995), and holds 5 more current directorships. The companies operate in Healthcare, Pharma and Chemicals. The 8 current companies with reported revenue have a combined latest revenue of ₹98.98 Cr; the largest is Ojas Medical Services Private Limited at ₹54.80 Cr (FY 2023). Earlier, Tarsem Kumar Ruby was a Director at Radiant Aviation Services Private Limited (2005–2007) and Director at India Health Services Private Limited (2013–2020) and 2 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 30 Jun 2015 | 2015 | ₹54.80 Cr (FY 2023) | Active | |
| Director | 02 May 2019 | 2019 | ₹25.60 Cr (FY 2025) | Active | |
| Director | 10 Jan 1995 | 1995 | ₹14.90 Cr (FY 2025) | Active | |
| Director | 24 Sep 2020 | 2020 | ₹2.38 Cr (FY 2025) | Active | |
| Director | 06 Aug 2020 | 2020 | ₹56.9 Lakh (FY 2022) | Active | |
| Director | 02 Jan 2006 | 2006 | ₹45.2 Lakh (FY 2017) | Active | |
| Director | 08 Jul 2020 | 2020 | ₹28 Lakh (FY 2025) | Active | |
| Director | 12 Jul 2020 | 2020 | ₹5,661 (FY 2022) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 05 Apr 2005 | 2005 | Active | ||
| Director | 05 Nov 2013 | 2013 | ₹3,216 (FY 2025) | Active | |
| Director | 13 Jan 2010 | 2010 | Strike Off | ||
| Director | 25 Jun 2019 | 2019 | ₹14.8 Lakh (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Tarsem Kumar Ruby
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Tarsem Kumar Ruby
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Tarsem Kumar Ruby
Tarsem Kumar Ruby currently holds 8 directorships: Ojas Medical Services Private Limited (Director, since 30 Jun 2015, revenue ₹54.80 Cr (FY 2023)); Raymed Ophthalmic Private Limited (Director, since 02 May 2019, revenue ₹25.60 Cr (FY 2025)); Raymed Pharmaceuticals Limited (Director, since 10 Jan 1995, revenue ₹14.90 Cr (FY 2025)); Aquavision Pharmaceuticals Private Limited (Director, since 24 Sep 2020, revenue ₹2.38 Cr (FY 2025)); Raymzon Trade Links Private Limited (Director, since 06 Aug 2020, revenue ₹56.9 Lakh (FY 2022)); and 3 more.
Tarsem Kumar Ruby was first appointed on 10 Jan 1995 as Director at Raymed Pharmaceuticals Limited. The most recent appointment on record is 24 Sep 2020 at Aquavision Pharmaceuticals Private Limited.
The 8 current companies of Tarsem Kumar Ruby that report revenue have a combined latest revenue of ₹98.98 Cr: Ojas Medical Services Private Limited ₹54.80 Cr (FY 2023); Raymed Ophthalmic Private Limited ₹25.60 Cr (FY 2025); Raymed Pharmaceuticals Limited ₹14.90 Cr (FY 2025); Aquavision Pharmaceuticals Private Limited ₹2.38 Cr (FY 2025); Raymzon Trade Links Private Limited ₹56.9 Lakh (FY 2022); and 3 more.
Tarsem Kumar Ruby held 4 earlier board appointments: Radiant Aviation Services Private Limited (Director, 05 Apr 2005 to 24 Aug 2007); India Health Services Private Limited (Director, 05 Nov 2013 to 27 Jan 2020); Sarv Medicare International Limited (Director, 13 Jan 2010 to 16 Sep 2010); Jyotiragamaya Academic Foundation (Director, 25 Jun 2019 to 30 Jun 2020).
The current boards of Tarsem Kumar Ruby's companies include Amar Nath Bhateja (Ojas Medical Services Private Limited), Harish Gupta (Ojas Medical Services Private Limited), Karan Deep Singh (Ojas Medical Services Private Limited), Lokesh Garg (Ojas Medical Services Private Limited), Sanjeev Kumar (Ojas Medical Services Private Limited), Sophia Misra (Ojas Medical Services Private Limited), among others.